Hemophilia Federation of America is a national nonprofit organization that assists, educates, and advocates for the bleeding disorders community.
Note: This is an edited form of a press release from Biogen. To read the original release in its entirety, click here. The first shipments of much-needed hemophilia therapy have started to arrive at treatment centers across the developing world Biogen, Swedish Orphan Biovitrum AB (Sobi) and the World Federation of Hemophilia (WFH) announced on Monday, October 12, 2015. […]
Note: This is an edited version of a press release from Biogen. To read the original release, click here. _____________________________________ Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] experienced low bleeding rates, Biogen and Swedish Orphan Biovitrum AB (Sobi) announced on Monday, August 10, […]
Biogen Idec and Swedish Orphan Biovitrum AB announced their intent to produce one billion international units (IUs) of clotting factor therapy for humanitarian aid programs in the developing world at the World Federation of Hemophilia (WFH) 2014 World Congress. Initially, the companies have committed to donating up to 500 million IUs to the World Federation […]
Sign up for E-mails, Dateline Newsletter, and other ways to stay connected.